Home/Filings/3/0001294002-07-000016
3//SEC Filing

ORCHESTRA THERAPEUTICS, INC. 3

Accession 0001294002-07-000016

CIK 0000817785operating

Filed

May 9, 8:00 PM ET

Accepted

May 10, 5:49 PM ET

Size

16.8 KB

Accession

0001294002-07-000016

Insider Transaction Report

Form 3
Period: 2007-05-01
Bartholomew Ricahrd M
VP, Research and Development
Holdings
  • Incentive Stock Option (right to buy)

    Exercise: $112.00From: 1998-01-21Exp: 2008-01-21Common Stock (15 underlying)
  • Non-Qualified Stock Option (right to buy)

    Exercise: $74.00From: 2005-07-18Exp: 2015-07-18Common Stock (750 underlying)
  • Common Stock

    3,976
  • 8% Convertible Note

    Exercise: $2.00Common Stock (12,500 underlying)
Footnotes (3)
  • [F1]Promissory note is convertible into common stock at any time at the option of the holder and is convertible at the option of the Company, subject to the satisfaction of certain conditions, including satisfaction of certain minimum price and liquidity requirements for the Company's common stock.
  • [F2]The note matures on January 1, 2008.
  • [F3]Represents the number of shares issuable upon conversion of the principal amount of the note. Accrued interest may be converted into common stock as well.

Issuer

ORCHESTRA THERAPEUTICS, INC.

CIK 0000817785

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000817785

Filing Metadata

Form type
3
Filed
May 9, 8:00 PM ET
Accepted
May 10, 5:49 PM ET
Size
16.8 KB